{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:52:34Z","timestamp":1788976354850,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/00265"],"award-info":[{"award-number":["PI19\/00265"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Salud, OFTARED","award":["RD16\/0008"],"award-info":[{"award-number":["RD16\/0008"]}]},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Salud, OFTARED","award":["RD16\/0008"],"award-info":[{"award-number":["RD16\/0008"]}]},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Salud, OFTARED","award":["RD16\/0008"],"award-info":[{"award-number":["RD16\/0008"]}]},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en Salud, OFTARED","award":["RD16\/0008"],"award-info":[{"award-number":["RD16\/0008"]}]},{"name":"Advanced Therapies Network, RICORS-TERAV","award":["RD21\/0017\/0009"],"award-info":[{"award-number":["RD21\/0017\/0009"]}]},{"name":"Advanced Therapies Network, RICORS-TERAV","award":["RD21\/0017\/0009"],"award-info":[{"award-number":["RD21\/0017\/0009"]}]},{"name":"Advanced Therapies Network, RICORS-TERAV","award":["RD21\/0017\/0009"],"award-info":[{"award-number":["RD21\/0017\/0009"]}]},{"name":"Advanced Therapies Network, RICORS-TERAV","award":["RD21\/0017\/0009"],"award-info":[{"award-number":["RD21\/0017\/0009"]}]},{"name":"Fundaci\u00f3n Multi\u00f3pticas"},{"name":"Red del complemento y Salud","award":["SAF2016-81876-REDT"],"award-info":[{"award-number":["SAF2016-81876-REDT"]}]},{"name":"Red del complemento y Salud","award":["SAF2016-81876-REDT"],"award-info":[{"award-number":["SAF2016-81876-REDT"]}]},{"name":"Red del complemento y Salud","award":["SAF2016-81876-REDT"],"award-info":[{"award-number":["SAF2016-81876-REDT"]}]},{"name":"Red del complemento y Salud","award":["SAF2016-81876-REDT"],"award-info":[{"award-number":["SAF2016-81876-REDT"]}]},{"name":"Red del complemento y Salud","award":["SAF2016-81876-REDT"],"award-info":[{"award-number":["SAF2016-81876-REDT"]}]},{"name":"Red del complemento de la Comunidad de Madrid","award":["Complemento 2-CM"],"award-info":[{"award-number":["Complemento 2-CM"]}]},{"name":"Red del complemento de la Comunidad de Madrid","award":["Complemento 2-CM"],"award-info":[{"award-number":["Complemento 2-CM"]}]},{"name":"Red del complemento de la Comunidad de Madrid","award":["Complemento 2-CM"],"award-info":[{"award-number":["Complemento 2-CM"]}]},{"name":"Red del complemento de la Comunidad de Madrid","award":["Complemento 2-CM"],"award-info":[{"award-number":["Complemento 2-CM"]}]},{"name":"Red del complemento de la Comunidad de Madrid","award":["Complemento 2-CM"],"award-info":[{"award-number":["Complemento 2-CM"]}]},{"name":"Carlos III Health Institute and co-financed by the European Union","award":["RD24\/0007\/0015"],"award-info":[{"award-number":["RD24\/0007\/0015"]}]},{"name":"Carlos III Health Institute and co-financed by the European Union","award":["RD24\/0007\/0015"],"award-info":[{"award-number":["RD24\/0007\/0015"]}]},{"name":"Carlos III Health Institute and co-financed by the European Union","award":["RD24\/0007\/0015"],"award-info":[{"award-number":["RD24\/0007\/0015"]}]},{"name":"Carlos III Health Institute and co-financed by the European Union","award":["RD24\/0007\/0015"],"award-info":[{"award-number":["RD24\/0007\/0015"]}]},{"name":"Inflammatory Diseases Network, RICORS-REI","award":["RD21\/0002\/0010"],"award-info":[{"award-number":["RD21\/0002\/0010"]}]},{"name":"Inflammatory Diseases Network, RICORS-REI","award":["RD21\/0002\/0010"],"award-info":[{"award-number":["RD21\/0002\/0010"]}]},{"name":"Inflammatory Diseases Network, RICORS-REI","award":["RD21\/0002\/0010"],"award-info":[{"award-number":["RD21\/0002\/0010"]}]},{"name":"Inflammatory Diseases Network, RICORS-REI","award":["RD21\/0002\/0010"],"award-info":[{"award-number":["RD21\/0002\/0010"]}]},{"name":"Inflammatory Diseases Network, RICORS-REI","award":["RD21\/0002\/0010"],"award-info":[{"award-number":["RD21\/0002\/0010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Choroidal neovascularization (CNV) and inflammation play an important role in retinal disease development and the acute phase reactant C-reactive protein (CRP) has been shown to contribute to Age-related macular degeneration (AMD) in vitro. Our aim was to evaluate whether monomeric and pentameric CRP (pCRP, mCRP) isoforms contribute to CNV in vivo and to characterize the mechanism of CRP dissociation in-vivo and in vitro. Both CRP isoforms were intravitreally (IVT) or intravenously (IV) injected in mice, CNV was laser-induced, retinography and fluorescein angiography were performed to evaluate edema. Lectin, mCRP, F4\/80 and C5b9 localization were assessed by immunofluorescence and visualized under a confocal microscope. CNV, intensity of fluorescence of mCRP (IF mCRP) was also quantified. To confirm pCRP dissociation in RPE cells and mice, pCRP was coupled to a fluorochrome and IVT injected. A statistical increase in CNV areas was observed in pCRP IVT injected males (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) while a statistical decrease was shown in females (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). After IV injection, pCRP males showed an increase in CNV areas only vs. mCRP injected mice (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and in females the injection of pCRP injected mice showed higher CNV areas vs. vehicle (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and vs. mCRP injected mice (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Retinal edema after IVT CRP injection was observed mainly in mCRP injected mice. In females there was an IF mCRP statistical decrease in pCRP IVT injected mice vs. vehicle and a statistical increase in pCRP IV injected mice vs. vehicle (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Mice injected with IVT isoforms showed F4\/80 positive cells and C5b-9 deposition around the CNV areas. mCRP labeling was observed in the intercellular space of the endothelial cells in the angiogenic area and detected in pCRP IVT injected animals, demonstrating the dissociation of pCRP into mCRP both in vitro and in vivo in proinflammatory microenvironments. In conclusion, CRP administration increased the area of CNV and the edema observed in the subretinal space, suggesting that CRP is activated in the CNV inflammatory environment. In addition, we demonstrated that pCRP dissociates in vivo into mCRP in damaged areas close to CNV, hypothesizing that the CNV process is exacerbated by mCRP.<\/jats:p>","DOI":"10.1038\/s41598-025-16631-z","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T12:20:44Z","timestamp":1756210844000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["C-reactive protein dissociation drives choroidal neovascularization in age-related macular degeneration"],"prefix":"10.1038","volume":"15","author":[{"given":"Maria","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Romero-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Recalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaione","family":"Bezunartea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite Moreno","family":"Ordu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idoia","family":"Belza-Zuazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Garc\u00eda-Layana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fern\u00e1ndez-Robredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Molins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"3","key":"16631_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"CJ Thomas","year":"2021","unstructured":"Thomas, C. J., Mirza, R. G. & Gill, M. K. Age-Related macular degeneration. Med. Clin. North Am. 105 (3), 473\u2013491 (2021).","journal-title":"Med. Clin. North Am."},{"issue":"34","key":"16631_CR2","doi-asserted-by":"publisher","first-page":"51942","DOI":"10.1007\/s11356-022-19278-9","volume":"29","author":"CL Liang","year":"2022","unstructured":"Liang, C. L. et al. Fine particulate matter measured by satellites predicts the risk of age-related macular degeneration in a longitudinal cohort study. Environ. Sci. Pollut Res. 29 (34), 51942\u201351950 (2022).","journal-title":"Environ. Sci. Pollut Res."},{"issue":"4","key":"16631_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris, F. L. et al. Clinical classification of Age-related macular degeneration. Ophthalmology 120 (4), 844\u2013851 (2013).","journal-title":"Ophthalmology"},{"issue":"10153","key":"16631_CR4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell, P., Liew, G., Gopinath, B. & Wong, T. Y. Age-related macular degeneration. Lancet 392 (10153), 1147\u20131159 (2018).","journal-title":"Lancet"},{"key":"#cr-split#-16631_CR5.1","unstructured":"Vyawahare, H. & Shinde, P. Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Cureus [Internet]. Sep 26 [cited 2024 Dec 18]"},{"key":"#cr-split#-16631_CR5.2","unstructured":"(2022). Available from: https:\/\/www.cureus.com\/articles\/109204-age-related-macular-degeneration-epidemiology-pathophysiology-diagnosis-and-treatment."},{"issue":"2","key":"16631_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.survophthal.2005.12.001","volume":"51","author":"LA Donoso","year":"2006","unstructured":"Donoso, L. A., Kim, D., Frost, A., Callahan, A. & Hageman, G. The role of inflammation in the pathogenesis of Age-related macular degeneration. Surv. Ophthalmol. 51 (2), 137\u2013152 (2006).","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"16631_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/eye.2016.177","volume":"31","author":"AD Dick","year":"2017","unstructured":"Dick, A. D. Doyne lecture 2016: intraocular health and the many faces of inflammation. Eye 31 (1), 87\u201396 (2017).","journal-title":"Eye"},{"issue":"45","key":"16631_CR8","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1073\/pnas.1403814111","volume":"111","author":"Y Kim","year":"2014","unstructured":"Kim, Y. et al. DICER1\/ Alu RNA dysmetabolism induces Caspase-8\u2013mediated cell death in age-related macular degeneration. Proc. Natl. Acad. Sci. USA. 111 (45), 16082\u201316087 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"16631_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1001\/jama.291.6.704","volume":"291","author":"JM Seddon","year":"2004","unstructured":"Seddon, J. M., Gensler, G., Milton, R. C., Klein, M. L. & Rifai, N. Association between C-Reactive protein and Age-Related macular degeneration. JAMA 291 (6), 704\u2013710 (2004).","journal-title":"JAMA"},{"key":"16631_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0084-392X(08)70298-3","volume":"2006","author":"JMJF Seddon","year":"2006","unstructured":"Seddon, J. M. J. F. Progression of Age-Related macular degeneration: prospective assessment of C-Reactive protein, Interleukin 6, and other cardiovascular biomarkers. Yearbook Ophthalmol. 2006, 114\u2013115 (2006).","journal-title":"Yearbook Ophthalmol."},{"issue":"12","key":"16631_CR11","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.ophtha.2005.07.004","volume":"112","author":"AK Vine","year":"2005","unstructured":"Vine, A. K., Stader, J., Branham, K., Musch, D. C. & Swaroop, A. Biomarkers of cardiovascular disease as risk factors for Age-Related macular degeneration. Ophthalmology 112 (12), 2076\u20132080 (2005).","journal-title":"Ophthalmology"},{"key":"16631_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3389\/fimmu.2018.00808","volume":"9","author":"B Molins","year":"2018","unstructured":"Molins, B., Romero-V\u00e1zquez, S., Fuentes-Prior, P., Adan, A. & Dick, A. D. C-Reactive protein as a therapeutic target in Age-Related macular degeneration. Front. Immunol. 9, 808 (2018).","journal-title":"Front. Immunol."},{"key":"16631_CR13","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.3389\/fimmu.2018.01862","volume":"9","author":"P Fernandez-Robredo","year":"2018","unstructured":"Fernandez-Robredo, P. et al. Novel association of high C-Reactive protein levels and A69S at risk alleles in wet Age-Related macular degeneration women. Front. Immunol. 9, 1862 (2018).","journal-title":"Front. Immunol."},{"issue":"2","key":"16631_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/09286586.2021.1910314","volume":"29","author":"BD Wagner","year":"2022","unstructured":"Wagner, B. D. et al. Association of systemic inflammatory factors with progression to advanced Age-related macular degeneration. Ophthalmic Epidemiol. 29 (2), 139\u2013148 (2022).","journal-title":"Ophthalmic Epidemiol."},{"issue":"1\u20133","key":"16631_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0162-3109(99)00007-7","volume":"42","author":"C Mold","year":"1999","unstructured":"Mold, C., Gewurz, H. & Du Clos, T. W. Regulation of complement activation by C-reactive protein. Immunopharmacology 42 (1\u20133), 23\u201330 (1999).","journal-title":"Immunopharmacology"},{"key":"16631_CR16","doi-asserted-by":"publisher","first-page":"599974","DOI":"10.3389\/fimmu.2020.599974","volume":"11","author":"JJE Koopman","year":"2021","unstructured":"Koopman, J. J. E., Van Essen, M. F., Rennke, H. G., De Vries, A. P. J. & Van Kooten, C. Deposition of the membrane attack complex in healthy and diseased human kidneys. Front. Immunol. 11, 599974 (2021).","journal-title":"Front. Immunol."},{"issue":"45","key":"16631_CR17","doi-asserted-by":"publisher","first-page":"30451","DOI":"10.1074\/jbc.M803648200","volume":"283","author":"S Hakobyan","year":"2008","unstructured":"Hakobyan, S. et al. Complement factor H binds to denatured rather than to native pentameric C-reactive protein. J. Biol. Chem. 283 (45), 30451\u201330460 (2008).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"16631_CR18","doi-asserted-by":"publisher","first-page":"22889","DOI":"10.1038\/srep22889","volume":"6","author":"B Molins","year":"2016","unstructured":"Molins, B. et al. Complement factor H binding of monomeric C-reactive protein downregulates Proinflammatory activity and is impaired with at risk polymorphic CFH variants. Sci. Rep. 6 (1), 22889 (2016).","journal-title":"Sci. Rep."},{"issue":"1","key":"16631_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1096\/fj.06-6722com","volume":"21","author":"S Ji","year":"2007","unstructured":"Ji, S. et al. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRPm. FASEB J. 21 (1), 284\u2013294 (2007).","journal-title":"FASEB J."},{"issue":"11","key":"16631_CR20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1515\/hsz-2015-0149","volume":"396","author":"Y Wu","year":"2015","unstructured":"Wu, Y., Potempa, L. A., El Kebir, D. & Filep, J. G. C-reactive protein and inflammation: conformational changes affect function. Biol. Chem. 396 (11), 1181\u20131197 (2015).","journal-title":"Biol. Chem."},{"issue":"1","key":"16631_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/eye.2016.216","volume":"31","author":"KR Chirco","year":"2017","unstructured":"Chirco, K. R., Sohn, E. H., Stone, E. M., Tucker, B. A. & Mullins, R. F. Structural and molecular changes in the aging choroid: implications for age-related macular degeneration. Eye (Lond). 31 (1), 10\u201325 (2017).","journal-title":"Eye (Lond)"},{"key":"16631_CR22","doi-asserted-by":"publisher","first-page":"17456","DOI":"10.1073\/pnas.0606234103","volume":"103","author":"PT Johnson","year":"2006","unstructured":"Johnson, P. T. et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. USA. 103, 17456\u201317461. https:\/\/doi.org\/10.1073\/pnas.0606234103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"16631_CR23","doi-asserted-by":"crossref","unstructured":"Romero-V\u00e1zquez, S., et al. Activation of C-reactive protein Proinflammatory phenotype in the blood retinal barrier in vitro: implications for age-related macular degeneration. Aging 12 (14), 13905\u201313923 (2020).","DOI":"10.18632\/aging.103655"},{"issue":"15","key":"16631_CR24","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.7150\/ijbs.49890","volume":"16","author":"W Tan","year":"2020","unstructured":"Tan, W., Zou, J., Yoshida, S., Jiang, B. & Zhou, Y. The role of inflammation in Age-Related macular degeneration. Int. J. Biol. Sci. 16 (15), 2989\u20133001 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"16631_CR25","doi-asserted-by":"crossref","unstructured":"Colak, E., Majkic-Singh, N., Zoric, L., Radosavljevic, A. & Kosanovic-Jakovic, N. The role of CRP and inflammation in the pathogenesis of age-related macular degeneration. Biochem. Med. 39\u201348. (2012).","DOI":"10.11613\/BM.2012.005"},{"issue":"7","key":"16631_CR26","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","volume":"14","author":"RF Mullins","year":"2000","unstructured":"Mullins, R. F., Russell, S. R., Anderson, D. H. & Hageman, G. S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14 (7), 835\u2013846 (2000).","journal-title":"FASEB J."},{"issue":"3","key":"16631_CR27","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","volume":"134","author":"DH Anderson","year":"2002","unstructured":"Anderson, D. H., Mullins, R. F., Hageman, G. S. & Johnson, L. V. A role for local inflammation in the formation of Drusen in the aging eye. Am. J. Ophthalmol. 134 (3), 411\u2013431 (2002).","journal-title":"Am. J. Ophthalmol."},{"issue":"14","key":"16631_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.65.14.15","volume":"65","author":"K Mulfaul","year":"2024","unstructured":"Mulfaul, K. et al. Elevation of granulocyte colony stimulating factor in human AMD donor RPE-Choroid. Invest. Ophthalmol. Vis. Sci. 65 (14), 15 (2024).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"16631_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.exer.2015.09.003","volume":"146","author":"KR Chirco","year":"2016","unstructured":"Chirco, K. R., Tucker, B. A., Stone, E. M. & Mullins, R. F. Selective accumulation of the complement membrane attack complex in aging choriocapillaris. Exp. Eye Res. 146, 393\u2013397 (2016).","journal-title":"Exp. Eye Res."},{"issue":"3","key":"16631_CR30","doi-asserted-by":"publisher","first-page":"C244","DOI":"10.1152\/ajpcell.00057.2016","volume":"312","author":"B Molins","year":"2017","unstructured":"Molins, B. et al. C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function. Am. J. Physiology-Cell Physiol. 312 (3), C244\u2013C253 (2017).","journal-title":"Am. J. Physiology-Cell Physiol."},{"issue":"4","key":"16631_CR31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S0002-9440(10)61202-3","volume":"167","author":"H Sun","year":"2005","unstructured":"Sun, H. et al. C-Reactive protein in atherosclerotic lesions. Am. J. Pathol. 167 (4), 1139\u20131148 (2005).","journal-title":"Am. J. Pathol."},{"issue":"1","key":"16631_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cardiores.2006.03.004","volume":"71","author":"E Paffen","year":"2006","unstructured":"Paffen, E. & Demaat, M. C-reactive protein in atherosclerosis: A causal factor? Cardiovascular. Res. 71 (1), 30\u201339 (2006).","journal-title":"Cardiovascular. Res."},{"issue":"4","key":"16631_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/diseases11040132","volume":"11","author":"DS Mouliou","year":"2023","unstructured":"Mouliou, D. S. & C-Reactive Protein Pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians. Diseases 11 (4), 132 (2023).","journal-title":"Diseases"},{"key":"16631_CR34","doi-asserted-by":"publisher","first-page":"1330913","DOI":"10.3389\/fimmu.2024.1330913","volume":"15","author":"L Giralt","year":"2024","unstructured":"Giralt, L. et al. C-reactive protein-complement factor H axis as a biomarker of activity in early and intermediate age-related macular degeneration. Front. Immunol. 15, 1330913 (2024).","journal-title":"Front. Immunol."},{"issue":"5","key":"16631_CR35","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00395-011-0191-y","volume":"106","author":"I Ahrens","year":"2011","unstructured":"Ahrens, I. et al. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic. Res. Cardiol. 106 (5), 879 (2011).","journal-title":"Basic. Res. Cardiol."},{"issue":"7","key":"16631_CR36","first-page":"724","volume":"65","author":"IA Bhutto","year":"2024","unstructured":"Bhutto, I. A., Moghadas, M., Jolly, S. J., McLeod, D. S. & Edwards, M. M. CRP activates choroidal mast cell degranulation and alterations in retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 65 (7), 724\u2013724 (2024).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"16631_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12974-024-03229-x","volume":"21","author":"R Dabouz","year":"2024","unstructured":"Dabouz, R., Abram, P., Rivera, J. C. & Chemtob, S. Mast cells promote choroidal neovascularization in a model of age-related macular degeneration. J. Neuroinflammation. 21 (1), 247 (2024).","journal-title":"J. Neuroinflammation"},{"key":"16631_CR38","doi-asserted-by":"crossref","unstructured":"Turu, M. M. et al. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression. BMC Cell Biol. 9(1), 47 (2008).","DOI":"10.1186\/1471-2121-9-47"},{"issue":"6","key":"16631_CR39","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1096\/fj.08-116962","volume":"23","author":"SR Ji","year":"2009","unstructured":"Ji, S. R. et al. Monomeric C-reactive protein activates endothelial cells via interaction with lipid raft microdomains. FASEB J. 23 (6), 1806\u20131816 (2009).","journal-title":"FASEB J."},{"issue":"12","key":"16631_CR40","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/BF00970589","volume":"20","author":"DB Stanimirovic","year":"1995","unstructured":"Stanimirovic, D. B., Wong, J., Ball, R. & Durkin, J. P. Free radical-induced endothelial membrane dysfunction at the site of blood-brain barrier: relationship between lipid peroxidation, Na,K-ATPase activity, and 51Cr release. Neurochem Res. 20 (12), 1417\u20131427 (1995).","journal-title":"Neurochem Res."},{"issue":"7","key":"16631_CR41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/archopht.123.7.914","volume":"123","author":"Histopathologic and Ultrastructural Features of Surgically Excised Subfoveal Choroidal Neovascular Lesions","year":"2005","unstructured":"Histopathologic and Ultrastructural Features of Surgically Excised Subfoveal Choroidal Neovascular Lesions. Submacular surgery trials report 7. Arch. Ophthalmol. 123 (7), 914 (2005).","journal-title":"Arch. Ophthalmol."},{"key":"16631_CR42","doi-asserted-by":"crossref","unstructured":"Apte, R. S., Richter, J., Herndon, J. & Ferguson, T. A. Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration. PLoS Med. 3(8), e310  (2006).","DOI":"10.1371\/journal.pmed.0030310"},{"issue":"1","key":"16631_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/rej.2007.0614","volume":"11","author":"DS Dace","year":"2008","unstructured":"Dace, D. S. & Apte, R. S. Effect of senescence on macrophage polarization and angiogenesis. Rejuven. Res. 11 (1), 177\u2013185 (2008).","journal-title":"Rejuven. Res."},{"issue":"2","key":"16631_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.exger.2003.10.023","volume":"39","author":"D Ham","year":"2004","unstructured":"Ham, D. & Skoryna, S. C. Cellular defense against oxidized low density lipoproteins and fibrillar amyloid beta in murine cells of monocyte origin with possible susceptibility to the oxidative stress induction. Exp. Gerontol. 39 (2), 225\u2013231 (2004).","journal-title":"Exp. Gerontol."},{"issue":"2","key":"16631_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1373\/clinchem.2008.108886","volume":"55","author":"S Devaraj","year":"2009","unstructured":"Devaraj, S., Singh, U. & Jialal, I. The evolving role of C-Reactive protein in atherothrombosis. Clin. Chem. 55 (2), 229\u2013238 (2009).","journal-title":"Clin. Chem."},{"issue":"5","key":"16631_CR46","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1161\/01.ATV.0000159890.10526.1e","volume":"25","author":"E Qamirani","year":"2005","unstructured":"Qamirani, E., Ren, Y., Kuo, L. & Hein, T. W. C-Reactive protein inhibits Endothelium-Dependent NO-Mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. ATVB 25 (5), 995\u20131001 (2005).","journal-title":"ATVB"},{"issue":"5","key":"16631_CR47","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/1043-4666(92)90079-7","volume":"4","author":"SP Ballou","year":"1992","unstructured":"Ballou, S. P. & Lozanski, G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4 (5), 361\u2013368 (1992).","journal-title":"Cytokine"},{"issue":"11","key":"16631_CR48","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1161\/01.ATV.0000241572.05292.fb","volume":"26","author":"U Singh","year":"2006","unstructured":"Singh, U. et al. C-Reactive protein decreases Interleukin-10 secretion in activated human Monocyte-Derived macrophages via Inhibition of Cyclic AMP production. ATVB 26 (11), 2469\u20132475 (2006).","journal-title":"ATVB"},{"issue":"2","key":"16631_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/07853890701749225","volume":"40","author":"SK Singh","year":"2008","unstructured":"Singh, S. K., Suresh, M. V., Voleti, B. & Agrawal, A. The connection between C-reactive protein and atherosclerosis. Ann. Med. 40 (2), 110\u2013120 (2008).","journal-title":"Ann. Med."},{"issue":"6","key":"16631_CR50","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/ATVBAHA.111.225508","volume":"31","author":"S Devaraj","year":"2011","unstructured":"Devaraj, S. & Jialal, I. C-Reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. ATVB 31 (6), 1397\u20131402 (2011).","journal-title":"ATVB"},{"issue":"6","key":"16631_CR51","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.3390\/ijms25063097","volume":"25","author":"Y Pastorello","year":"2024","unstructured":"Pastorello, Y. et al. mCRP-Induced focal adhesion Kinase-Dependent monocyte aggregation and M1 polarization, which was partially blocked by the C10M inhibitor. IJMS 25 (6), 3097 (2024).","journal-title":"IJMS"},{"key":"16631_CR52","doi-asserted-by":"publisher","first-page":"7053","DOI":"10.2147\/JIR.S316816","volume":"14","author":"Z Zha","year":"2021","unstructured":"Zha, Z. et al. Monomeric CRP aggravates myocardial injury after myocardial infarction by polarizing the macrophage to Pro-Inflammatory phenotype through JNK signaling pathway. JIR 14, 7053\u20137064 (2021).","journal-title":"JIR"},{"key":"16631_CR53","doi-asserted-by":"crossref","unstructured":"Ciubotaru, I. et al. Production of Modified C-Reactive Protein in U937-Derived Macrophages. Exp. Biol. Med. (Maywood). 230(10), 762\u2013770 (2005).","DOI":"10.1177\/153537020523001010"},{"issue":"6","key":"16631_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00417-007-0749-4","volume":"246","author":"A Lommatzsch","year":"2008","unstructured":"Lommatzsch, A. et al. Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch. Clin. Exp. Ophthalmol. 246 (6), 803\u2013810 (2008).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"16631_CR55","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1167\/iovs.12-10442","volume":"53","author":"QJ Ding","year":"2012","unstructured":"Ding, Q. J., Cook, A. C., Dumitrescu, A. V. & Kuehn, M. H. Lack of Immunoglobulins does not prevent C1q binding to RGC and does not alter the progression of experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 53 (10), 6370 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"16631_CR56","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3389\/fimmu.2018.00675","volume":"9","author":"JR Thiele","year":"2018","unstructured":"Thiele, J. R. et al. A conformational change in C-Reactive protein enhances leukocyte recruitment and reactive oxygen species generation in ischemia\/reperfusion injury. Front. Immunol. 9, 675 (2018).","journal-title":"Front. Immunol."},{"key":"16631_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.exer.2014.05.003","volume":"124","author":"KA Toops","year":"2014","unstructured":"Toops, K. A., Tan, L. X. & Lakkaraju, A. A detailed three-step protocol for live imaging of intracellular traffic in polarized primary Porcine RPE monolayers. Exp. Eye Res. 124, 74\u201385 (2014).","journal-title":"Exp. Eye Res."},{"issue":"4","key":"16631_CR58","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/antiox12040884","volume":"12","author":"J Gonz\u00e1lez-Zamora","year":"2023","unstructured":"Gonz\u00e1lez-Zamora, J. et al. Matrix metalloproteinase 13 is associated with Age-Related choroidal neovascularization. Antioxidants 12 (4), 884 (2023).","journal-title":"Antioxidants"},{"key":"16631_CR59","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.omtm.2019.10.013","volume":"15","author":"M Hernandez","year":"2019","unstructured":"Hernandez, M. et al. Preclinical evaluation of a Cell-Based gene therapy using the sleeping beauty transposon system in choroidal neovascularization. Mol. Therapy - Methods Clin. Dev. 15, 403\u2013417 (2019).","journal-title":"Mol. Therapy - Methods Clin. Dev."},{"key":"16631_CR60","doi-asserted-by":"crossref","unstructured":"Haydinger, C. D., et al. Mechanisms of macular edema. Front. Med. 10, 1128811 (2023).","DOI":"10.3389\/fmed.2023.1128811"},{"key":"16631_CR61","doi-asserted-by":"crossref","unstructured":"Torzewski, J., et al. C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries. ATVB. 18(9), 1386\u20131392 (1998).","DOI":"10.1161\/01.ATV.18.9.1386"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16631-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16631-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16631-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:20:39Z","timestamp":1757442039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16631-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16631"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16631-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted following the European Community guidelines for ethical animal care and use of laboratory animals (Directive 2010\/63\/UE) and approved by the University of Navarra Animal Research Review Committee (091\u2009\u2212\u200920).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31408"}}